Arena Says Patient Programs Will Offset Belviq’s Premium Price For Some

The obesity pill will be priced at a slight premium to Vivus’ rival drug Qsymia, but Arena CEO says the amount patients will actually pay will vary based on coupon and rebate programs.

More from Market Access

More from Pink Sheet